CBPO [China Biologic Products] 8-K: FOR RELEASE October 11, 2016 China Biologic Receives

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-10-11
Original SEC Filing: Click here


Webplus: CBPO/20161011/8-K/2_EX-99.1/000.htm SEC Original: v450369_ex99-1.htm
FOR RELEASE October 11, 2016 China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III BEIJING, China – October 11, 2016 – ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism. No manufacturer in China currently offers plasma-derived ATIII product. China Biologic expects to commence clinical trials




Webplus: CBPO/20161011/8-K/1/000.htm SEC Original: v450369_8k.htm



Company Info:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-10-11CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125

Home Page Forums

By | 2016-10-11T14:44:59+00:00 October 11th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar